One of the critical events in tumor growth and metastasis is the inter
action between tumor cells and host tissue stroma, mediated by differe
nt adhesion receptor repertoires in different tumor cell types. Severa
l lines of evidence indicate that interaction between the hyaluronan r
eceptor CD44, expressed on tumor cells, and host tissue stromal hyalur
onan can enhance growth and invasiveness of certain tumors. Disruption
of CD44-hyaluronan interaction by soluble recombinant CD44 has been s
hown to inhibit tumor formation by lymphoma and melanoma cells transfe
cted with CD44. Since hyaluronan is a ubiquitous glycosaminoglycan pol
ymer from which oligosaccharides of defined size can be readily purifi
ed, we tested the ability of hyaluronan oligomers to inhibit tumor for
mation by subcutaneously (s.c.) injected B16F10 melanoma cells. Our re
sults indicate that hyaluronan oligomers injected at concentrations as
low as 1 mg/ml can markedly inhibit B16F10 melanoma growth, providing
a potentially attractive reagent for the control of local tumor devel
opment. (C) 1998 Wiley-Liss, Inc.